메뉴 건너뛰기




Volumn 877, Issue 3, 2009, Pages 316-322

HPLC methods for determination of two novel thiosemicarbazone anti-cancer drugs (N4mT and Dp44mT) in plasma and their application to in vitro plasma stability of these agents

Author keywords

2 hydroxy 1 naphthylaldehyde 4 methyl 3 thiosemicarbazone (N4mT); Di 2 pyridylketone 4,4 dimethyl 3 thiosemicarbazone (Dp44mT); HPLC; Stability; Thiosemicarbazone

Indexed keywords

2-HYDROXY-1-NAPHTHYLALDEHYDE-4-METHYL-3-THIOSEMICARBAZONE (N4MT); ANTI-CANCER DRUGS; DI-2-PYRIDYLKETONE-4,4-DIMETHYL-3-THIOSEMICARBAZONE (DP44MT); HPLC; HPLC COLUMNS; HPLC METHODS; IN VITRO; PLASMA SAMPLES; THIOSEMICARBAZONE; THIOSEMICARBAZONES;

EID: 58149186443     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2008.11.044     Document Type: Article
Times cited : (21)

References (21)
  • 20
    • 58149180531 scopus 로고    scopus 로고
    • CDER and CVM. Bioanalytical Method Validation, Guidance for Industry, May 2001, http://www.fda.gov/cder/guidance/4252fnl.htm).
    • CDER and CVM. Bioanalytical Method Validation, Guidance for Industry, May 2001, http://www.fda.gov/cder/guidance/4252fnl.htm).


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.